避妊具市場：製品タイプ別（医薬品、デバイス）、年齢層別（15～44歳、44歳以上）、エンドユーザー別（一般家庭、診療所、病院）。世界の機会分析および産業予測、2020-2030年

Contraceptives Market By Product Type (Drugs, Devices), By Age Group (15-44 Years, Above 44 Years), By End User (Households, Clinics, Hospitals): Global Opportunity Analysis and Industry Forecast, 2020-2030

世界の避妊薬市場は、2020年には263億2150万ドルで、2030年には505億9580万ドルに達すると予測され、2020年から2030年までのCAGRは6.5％で成長するとされています。避妊とは、薬物や器具を用いて妊娠を防ぐ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,939 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	192	英語

サマリー

世界の避妊薬市場は、2020年には263億2150万ドルで、2030年には505億9580万ドルに達すると予測され、2020年から2030年までのCAGRは6.5％で成長するとされています。

避妊とは、薬物や器具を用いて妊娠を防ぐ方法です。バースコントロール、フォーティリティコントロールとも呼ばれる。避妊に用いられる機器や薬剤は、精子と卵子が受精する正常なプロセスを阻害し、妊娠を防ぐ。

家族計画の必要性と意図しない妊娠の防止に向けた焦点の上昇は、市場の成長を加速させます。また、若い女性における避妊の普及と教育水準の向上が、市場の成長を後押ししています。さらに、10代の妊娠に関連する健康問題、現代の避妊に対する意識の高まり、計画外の妊娠を避けるための重要な方法としての経口ピルの使用率上昇が、避妊薬市場の成長をさらに後押ししています。
高い吸収率、生殖能力を持つ女性の労働力への参加の増加、人々の間で避妊製品に関する高い認知度が、世界の避妊具市場の成長を後押ししています。また、インド、ブラジル、アフリカなどの発展途上国における人口の可処分所得の増加、ひいては避妊具の採用率の上昇も、世界の避妊具市場の成長を後押ししています。例えば、インドの人口の可処分所得は、2019年から2021年にかけて1.8%増加しました。
しかし、避妊具の使用に関連する健康リスク、代替避妊法の利用可能性、社会的受容の欠如が避妊具市場の成長に悪影響を与える可能性があります。

Cooper Companies、Veru Inc.、Pfizer Inc.などの大手企業は、市場での競争を維持するために、製品ポートフォリオを改善するための買収戦略を採用しています。例えば、2021年3月、クーパー社は、出産に伴うリスクを軽減するために、緊急産科で使用する革新的な産科製品を設計・開発した民間の医療機器企業の買収を完了しました。このような事例は、市場成長のために主要なプレーヤーに有利な機会を提供することが期待されます。
避妊薬市場は、製品、年齢層、エンドユーザー、地域によって区分されています。避妊薬と避妊具は、避妊薬市場の2つの主要製品カテゴリーです。避妊薬にはさらに、経口（ピル）避妊薬、注射剤、局所避妊薬に分類されます。経口避妊薬市場は、女性に広く使用されている経口ピルによって、避妊薬市場の中で最も大きな規模を誇っています。これは主に、妊娠を防ぐのに99%まで高い効果があることが証明されているためです。2020年の売上高は医薬品部門が最も高い。
また、避妊具はさらに、コンドーム、IUD、ダイアフラム、スポンジ、パッチ、インプラント、膣リングに分類されます。収益面では、コンドームが最も一般的に使用されている避妊具であり、2020年の避妊具市場シェアの約3分の2を占めています。しかし、「IUD」は勢いを増し、予測期間中はより速いペースで成長することが予想されます。年齢層別では、15～44歳と44歳以上に分けられます。2020年には15-44歳のセグメントが市場を支配する。
エンドユーザー別では、家庭、診療所、病院に区分される。2020年には、家庭用セグメントが最も高い収益を上げた。
COVID-19の大流行により、世界の避妊具市場の多くの企業は、病気の蔓延を抑制するための新たな政府規制を遵守するために、短期間の事業停止を余儀なくされました。この操業停止は、避妊具の世界市場の収益に直接影響を及ぼします。また、COVID-19の流行期間中は、原材料や人手の不足から工業製品の製造が停止し、ダスロックダウンが実施されました。さらに、この分野で事業を展開する企業には、新たな荷物が届かなかった。したがって、産業活動の停止や数ヶ月間の閉鎖は世界の避妊薬市場に影響を与え、予測期間中に市場はゆっくりとした回復を目撃すると予想されます。
地域別では、北米、欧州、アジア太平洋地域、LAMEAで分析されています。北米地域は予測期間中、最も高い市場シェアを占めると予想されます。
競合分析
本レポートでは、避妊具市場で事業を展開する主要企業、すなわち、Veru Inc.、Teva Pharmaceutical Industries Limited、Abbvie Inc.、Bayer AG、Pfizer, Inc、Cooper Companies, Inc、Ansell LTD、Mayer Laboratories、Merck & Co, Inc、および Church & Dwight, Co.

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: CONTRACEPTIVES MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Drugs
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: CONTRACEPTIVES MARKET, BY AGE GROUP
5.1 Overview
5.1.1 Market size and forecast
5.2 15-44 Years
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Above 44 Years
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: CONTRACEPTIVES MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Households
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Hospitals
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: CONTRACEPTIVES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Age Group
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product Type
7.2.5.1.2 Market size and forecast, by Age Group
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product Type
7.2.5.2.2 Market size and forecast, by Age Group
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product Type
7.2.5.3.2 Market size and forecast, by Age Group
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Age Group
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product Type
7.3.5.1.2 Market size and forecast, by Age Group
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 Italy
7.3.5.2.1 Market size and forecast, by Product Type
7.3.5.2.2 Market size and forecast, by Age Group
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 France
7.3.5.3.1 Market size and forecast, by Product Type
7.3.5.3.2 Market size and forecast, by Age Group
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Spain
7.3.5.4.1 Market size and forecast, by Product Type
7.3.5.4.2 Market size and forecast, by Age Group
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Rest of Europe
7.3.5.5.1 Market size and forecast, by Product Type
7.3.5.5.2 Market size and forecast, by Age Group
7.3.5.5.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Age Group
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product Type
7.4.5.1.2 Market size and forecast, by Age Group
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product Type
7.4.5.2.2 Market size and forecast, by Age Group
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product Type
7.4.5.3.2 Market size and forecast, by Age Group
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Product Type
7.4.5.4.2 Market size and forecast, by Age Group
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Product Type
7.4.5.5.2 Market size and forecast, by Age Group
7.4.5.5.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Age Group
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Latin America
7.5.5.1.1 Market size and forecast, by Product Type
7.5.5.1.2 Market size and forecast, by Age Group
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Middle East
7.5.5.2.1 Market size and forecast, by Product Type
7.5.5.2.2 Market size and forecast, by Age Group
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 Africa
7.5.5.3.1 Market size and forecast, by Product Type
7.5.5.3.2 Market size and forecast, by Age Group
7.5.5.3.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Merck & Co Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Pfizer Inc
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Abbvie Inc
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Ansell Ltd
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Bayer AG
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Church & Dwight Co Inc
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Teva Pharmaceutical Industries Limited
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 The Cooper Companies Inc
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Veru Inc
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Mayer Laboratories Inc
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 2. CONTRACEPTIVES MARKET REVENUE, FOR DRUGS, BY REGION , 2020-2030,($MILLION)
TABLE 3. CONTRACEPTIVES MARKET DRUGS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. CONTRACEPTIVES MARKET REVENUE, FOR DEVICES, BY REGION , 2020-2030,($MILLION)
TABLE 5. CONTRACEPTIVES MARKET DEVICES BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. GLOBAL CONTRACEPTIVES MARKET, BY AGE GROUP, 2020-2030,($MILLION)
TABLE 7. CONTRACEPTIVES MARKET REVENUE, FOR 15-44 YEARS, BY REGION , 2020-2030,($MILLION)
TABLE 8. CONTRACEPTIVES MARKET 15-44 YEARS BY COUNTRY, 2020-2030,($MILLION)
TABLE 9. CONTRACEPTIVES MARKET REVENUE, FOR ABOVE 44 YEARS, BY REGION , 2020-2030,($MILLION)
TABLE 10. CONTRACEPTIVES MARKET ABOVE 44 YEARS BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. GLOBAL CONTRACEPTIVES MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 12. CONTRACEPTIVES MARKET REVENUE, FOR HOUSEHOLDS, BY REGION , 2020-2030,($MILLION)
TABLE 13. CONTRACEPTIVES MARKET HOUSEHOLDS BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. CONTRACEPTIVES MARKET REVENUE, FOR CLINICS, BY REGION , 2020-2030,($MILLION)
TABLE 15. CONTRACEPTIVES MARKET CLINICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 16. CONTRACEPTIVES MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
TABLE 17. CONTRACEPTIVES MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
TABLE 18. CONTRACEPTIVES MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 19. NORTH AMERICA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 20. NORTH AMERICA CONTRACEPTIVES MARKET, BY AGE GROUP, 2020-2030,($MILLION)
TABLE 21. NORTH AMERICA CONTRACEPTIVES MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 22. NORTH AMERICA CONTRACEPTIVES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 23. U.S. CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 24. U.S. CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 25. U.S. CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 26. CANADA CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 27. CANADA CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 28. CANADA CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 29. MEXICO CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 30. MEXICO CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 31. MEXICO CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 32. EUROPE CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 33. EUROPE CONTRACEPTIVES MARKET, BY AGE GROUP, 2020-2030,($MILLION)
TABLE 34. EUROPE CONTRACEPTIVES MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 35. EUROPE CONTRACEPTIVES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 36. GERMANY CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 37. GERMANY CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 38. GERMANY CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 39. ITALY CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 40. ITALY CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 41. ITALY CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 42. FRANCE CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 43. FRANCE CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 44. FRANCE CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 45. SPAIN CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 46. SPAIN CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 47. SPAIN CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 48. REST OF EUROPE CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 49. REST OF EUROPE CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 50. REST OF EUROPE CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 51. ASIA-PACIFIC CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 52. ASIA-PACIFIC CONTRACEPTIVES MARKET, BY AGE GROUP, 2020-2030,($MILLION)
TABLE 53. ASIA-PACIFIC CONTRACEPTIVES MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 54. ASIA-PACIFIC CONTRACEPTIVES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 55. CHINA CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 56. CHINA CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 57. CHINA CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 58. JAPAN CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 59. JAPAN CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 60. JAPAN CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 61. INDIA CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 62. INDIA CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 63. INDIA CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 64. SOUTH KOREA CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 65. SOUTH KOREA CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 66. SOUTH KOREA CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 67. REST OF ASIA-PACIFIC CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 68. REST OF ASIA-PACIFIC CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 69. REST OF ASIA-PACIFIC CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 70. LAMEA CONTRACEPTIVES MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 71. LAMEA CONTRACEPTIVES MARKET, BY AGE GROUP, 2020-2030,($MILLION)
TABLE 72. LAMEA CONTRACEPTIVES MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 73. LAMEA CONTRACEPTIVES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 74. LATIN AMERICA CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 75. LATIN AMERICA CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 76. LATIN AMERICA CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 77. MIDDLE EAST CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 78. MIDDLE EAST CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 79. MIDDLE EAST CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 80. AFRICA CONTRACEPTIVES MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 81. AFRICA CONTRACEPTIVES MARKET BY AGE GROUP 2020-2030,($MILLION)
TABLE 82. AFRICA CONTRACEPTIVES MARKET BY END USER 2020-2030,($MILLION)
TABLE 83.MERCK & CO INC: COMPANY SNAPSHOT
TABLE 84.MERCK & CO INC: OPERATING SEGMENTS
TABLE 85.MERCK & CO INC: PRODUCT PORTFOLIO
TABLE 86.MERCK & CO INC: NET SALES,
TABLE 87.MERCK & CO INC: KEY STRATERGIES
TABLE 88.PFIZER INC: COMPANY SNAPSHOT
TABLE 89.PFIZER INC: OPERATING SEGMENTS
TABLE 90.PFIZER INC: PRODUCT PORTFOLIO
TABLE 91.PFIZER INC: NET SALES,
TABLE 92.PFIZER INC: KEY STRATERGIES
TABLE 93.ABBVIE INC: COMPANY SNAPSHOT
TABLE 94.ABBVIE INC: OPERATING SEGMENTS
TABLE 95.ABBVIE INC: PRODUCT PORTFOLIO
TABLE 96.ABBVIE INC: NET SALES,
TABLE 97.ABBVIE INC: KEY STRATERGIES
TABLE 98.ANSELL LTD: COMPANY SNAPSHOT
TABLE 99.ANSELL LTD: OPERATING SEGMENTS
TABLE 100.ANSELL LTD: PRODUCT PORTFOLIO
TABLE 101.ANSELL LTD: NET SALES,
TABLE 102.ANSELL LTD: KEY STRATERGIES
TABLE 103.BAYER AG: COMPANY SNAPSHOT
TABLE 104.BAYER AG: OPERATING SEGMENTS
TABLE 105.BAYER AG: PRODUCT PORTFOLIO
TABLE 106.BAYER AG: NET SALES,
TABLE 107.BAYER AG: KEY STRATERGIES
TABLE 108.CHURCH & DWIGHT CO INC: COMPANY SNAPSHOT
TABLE 109.CHURCH & DWIGHT CO INC: OPERATING SEGMENTS
TABLE 110.CHURCH & DWIGHT CO INC: PRODUCT PORTFOLIO
TABLE 111.CHURCH & DWIGHT CO INC: NET SALES,
TABLE 112.CHURCH & DWIGHT CO INC: KEY STRATERGIES
TABLE 113.TEVA PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT
TABLE 114.TEVA PHARMACEUTICAL INDUSTRIES LIMITED: OPERATING SEGMENTS
TABLE 115.TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT PORTFOLIO
TABLE 116.TEVA PHARMACEUTICAL INDUSTRIES LIMITED: NET SALES,
TABLE 117.TEVA PHARMACEUTICAL INDUSTRIES LIMITED: KEY STRATERGIES
TABLE 118.THE COOPER COMPANIES INC: COMPANY SNAPSHOT
TABLE 119.THE COOPER COMPANIES INC: OPERATING SEGMENTS
TABLE 120.THE COOPER COMPANIES INC: PRODUCT PORTFOLIO
TABLE 121.THE COOPER COMPANIES INC: NET SALES,
TABLE 122.THE COOPER COMPANIES INC: KEY STRATERGIES
TABLE 123.VERU INC: COMPANY SNAPSHOT
TABLE 124.VERU INC: OPERATING SEGMENTS
TABLE 125.VERU INC: PRODUCT PORTFOLIO
TABLE 126.VERU INC: NET SALES,
TABLE 127.VERU INC: KEY STRATERGIES
TABLE 128.MAYER LABORATORIES INC: COMPANY SNAPSHOT
TABLE 129.MAYER LABORATORIES INC: OPERATING SEGMENTS
TABLE 130.MAYER LABORATORIES INC: PRODUCT PORTFOLIO
TABLE 131.MAYER LABORATORIES INC: NET SALES,
TABLE 132.MAYER LABORATORIES INC: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.CONTRACEPTIVES MARKET SEGMENTATION
FIGURE 2.CONTRACEPTIVES MARKET,2020-2030
FIGURE 3.CONTRACEPTIVES MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.CONTRACEPTIVES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.CONTRACEPTIVES MARKET,BY PRODUCT TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DRUGS CONTRACEPTIVES MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DEVICES CONTRACEPTIVES MARKET,2020-2030(%)
FIGURE 14.CONTRACEPTIVES MARKET,BY AGE GROUP,2020(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF 15-44 YEARS CONTRACEPTIVES MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ABOVE 44 YEARS CONTRACEPTIVES MARKET,2020-2030(%)
FIGURE 17.CONTRACEPTIVES MARKET,BY END USER,2020(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOUSEHOLDS CONTRACEPTIVES MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CLINICS CONTRACEPTIVES MARKET,2020-2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CONTRACEPTIVES MARKET,2020-2030(%)
FIGURE 21.CONTRACEPTIVES MARKET BY REGION,2020
FIGURE 22.U.S. CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 23.CANADA CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 24.MEXICO CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 25.GERMANY CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 26.ITALY CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 27.FRANCE CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 28.SPAIN CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 29.REST OF EUROPE CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 30.CHINA CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 31.JAPAN CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 32.INDIA CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 33.SOUTH KOREA CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 34.REST OF ASIA-PACIFIC CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 35.LATIN AMERICA CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 36.MIDDLE EAST CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 37.AFRICA CONTRACEPTIVES MARKET,2020-2030($MILLION)
FIGURE 38. TOP WINNING STRATEGIES, BY YEAR
FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 42.COMPETITIVE DASHBOARD
FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 44.MERCK & CO INC.: NET SALES ,($MILLION)
FIGURE 45.PFIZER INC.: NET SALES ,($MILLION)
FIGURE 46.ABBVIE INC.: NET SALES ,($MILLION)
FIGURE 47.ANSELL LTD.: NET SALES ,($MILLION)
FIGURE 48.BAYER AG.: NET SALES ,($MILLION)
FIGURE 49.CHURCH & DWIGHT CO INC.: NET SALES ,($MILLION)
FIGURE 50.TEVA PHARMACEUTICAL INDUSTRIES LIMITED.: NET SALES ,($MILLION)
FIGURE 51.THE COOPER COMPANIES INC.: NET SALES ,($MILLION)
FIGURE 52.VERU INC.: NET SALES ,($MILLION)
FIGURE 53.MAYER LABORATORIES INC.: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The global contraceptives market was valued at $26,321.5 million in 2020 and is projected to reach $50,595.8 million by 2030, growing at a CAGR of 6.5% from 2020 to 2030.

Contraception is a method of preventing pregnancy using drugs or a device. It is also known as birth control and fertility control. The devices or drugs used in contraception interfere with the normal process of sperm-ovum fertilization to prevent pregnancy.

Rise in focus towards the need of family planning and preventing unintended pregnancy fuels the market growth. In addition, increase in use of contraception in young women and rise in higher educational attainment propels the market growth. Moreover, health issues associated with teenage pregnancies, increase in awareness of modern contraception, and rise in use of oral pills as a key method to avoid unplanned pregnancy further drive the contraceptives market growth.
High absorption rate, and rise in participation of reproductive women in labor force, and high awareness about contraceptive products among population, which drives the growth of the global contraceptive market. In addition, rise in disposable income of population in developing countries such as India, Brazil, Africa, and others, which in turn, rise in adoption of contraceptives products, boost the growth of the global contraceptives market. For instance, the disposable income of Indian population grew by 1.8% from 2019 to 2021.
However, health risks associated with the use of contraceptives, availability of alternate contraceptive methods, and lack of social acceptance might adversely affect the contraceptives market growth.

Major players such as Cooper Companies, Veru Inc., Pfizer Inc. and others are adopting the acquisition strategy to improve their product portfolio to maintain competition in the market. For instance, in March 2021, Cooper completed the acquisition of a privately-held medical device company that designed and developed an innovative obstetric product for use in urgent obstetrics to reduce risks associated with childbirth. Such instances are expected to provide lucrative opportunities for the major players for the growth of the market.
The contraceptives market is segmented on the basis of product, age group, end user, and geography. Contraceptive drugs and devices are two major product categories of the contraceptives market. Contraceptive drugs are further categorized into oral (pills), injectable, and topical contraceptives. The oral contraceptives industry is the largest within the contraceptive drug market owing to the widespread use of oral pills by women. This is mainly because they are proven to be highly effective, up to 99% in preventing pregnancy. Drugs segment generated the highest revenue in 2020.
In addition, contraceptive devices are further categorized into condoms, IUDs, diaphragms, sponges, patches, implants, and vaginal rings. In terms of revenue, condoms are the most commonly used contraceptive devices, accounting for around two-thirds of the contraceptives market share in 2020. However, IUDs’ gain momentum and are expected to grow at a faster pace during the forecasting period. By age group, the market is divided into 15-44 years, and above 44 years. 15-44 years segment dominate the market in 2020.
On the basis of end user, the market is segmented into households, clinics, and hospitals. Households segment generated the highest revenue in 2020.
The COVID-19 pandemic forced many companies in the global contraceptives market to halt business operations for a short term to comply with new government regulations to curb the spread of the disease. This halt in operations directly impacts revenue flow of the global contraceptives market. In addition, halt in manufacturing of industrial products was witnessed due to lack of raw materials and manpower das lockdowns were imposed during the COVID-19 pandemic. Further, no new consignments were received by companies operating in this sector. Hence, halt in industrial activities and lockdowns for several months affected the global contraceptives market and the market is anticipated to witness a slow recovery during the forecast period.
By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America region is expected to hold the highest market share during the forecast period.
COMPETITION ANALYSIS
The report provides a comprehensive analysis of the key players that operate in the contraceptives market, namely, Veru Inc., Teva Pharmaceutical Industries Limited, Abbvie Inc., Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他（治療を主目的としない薬物））の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

避妊具市場：製品タイプ別（医薬品、デバイス）、年齢層別（15～44歳、44歳以上）、エンドユーザー別（一般家庭、診療所、病院）。世界の機会分析および産業予測、2020-2030年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他（治療を主目的としない薬物））の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?